Loading…

Pharmacologic treatment of binge eating disorder

Objective To review the findings from pharmacologic trials of binge eating disorder (BED) and to provide guidelines for pharmacologic treatment. Methods The literature was searched for studies of pharmacologic treatment of BED and related conditions, such as nonpurging bulimia nervosa. Results Place...

Full description

Saved in:
Bibliographic Details
Published in:The International journal of eating disorders 2003, Vol.34 (S1), p.S74-S88
Main Authors: Carter, William P., Hudson, James I., Lalonde, Justine K., Pindyck, Lindsay, McElroy, Susan L., Pope Jr, Harrison G.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective To review the findings from pharmacologic trials of binge eating disorder (BED) and to provide guidelines for pharmacologic treatment. Methods The literature was searched for studies of pharmacologic treatment of BED and related conditions, such as nonpurging bulimia nervosa. Results Placebo‐controlled studies of desipramine, fluvoxamine, fluoxetine, sertraline, citalopram, dexfenfluramine, sibutramine, and topiramate have demonstrated the efficacy of these agents in the treatment of BED. An open trial of venlafaxine has offered preliminary evidence for the efficacy of this medication. Guidelines for pharmacologic management of BED are provided. Conclusions The literature offers support for the use of agents from three categories of medication (antidepressants, appetite suppressants, and anticonvulsants) in the treatment of BED. © 2003 by Wiley Periodicals, Inc. Int J Eat Disord 34: S74–S88, 2003.
ISSN:0276-3478
1098-108X
DOI:10.1002/eat.10207